L
LogicBio Therapeutics Inc
F:0IF
LogicBio Therapeutics Inc
F:0IF
Price:
2.04
EUR
Market Closed
Market Cap:
€67.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
LogicBio Therapeutics Inc
F:0IF
|
US |
|
Byotrol PLC
LSE:BYOT
|
UK |
|
Blue Line Protection Group Inc
OTC:BLPG
|
US |
|
Shanghai Fengyuzhu Culture Technology Co Ltd
SSE:603466
|
CN |
|
Applied DNA Sciences Inc
NASDAQ:APDN
|
US |
|
Archtis Ltd
ASX:AR9
|
AU |
|
APN Industria REIT
ASX:ADI
|
AU |
|
S
|
Standard Industries Ltd
NSE:SIL
|
IN |
|
HUYA Inc
NYSE:HUYA
|
CN |
|
T
|
Tigo Energy Inc
NASDAQ:TYGO
|
US |
Balance Sheet
Balance Sheet Decomposition
LogicBio Therapeutics Inc
LogicBio Therapeutics Inc
Balance Sheet Decomposition is not available for
LogicBio Therapeutics Inc
LogicBio Therapeutics Inc
Balance Sheet
LogicBio Therapeutics Inc
LogicBio Therapeutics Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
18
|
14
|
1
|
1
|
1
|
4
|
|
| Cash |
18
|
14
|
1
|
1
|
0
|
4
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Receivables |
2
|
2
|
1
|
1
|
0
|
2
|
|
| Accounts Receivables |
2
|
1
|
1
|
0
|
0
|
2
|
|
| Other Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
2
|
2
|
13
|
0
|
0
|
2
|
|
| Total Current Assets |
23
|
18
|
15
|
1
|
2
|
9
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
3
|
508
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
0
|
508
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
95
|
|
| Intangible Assets |
11
|
29
|
3
|
0
|
0
|
1
|
|
| Goodwill |
42
|
47
|
2
|
0
|
0
|
154
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
473
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
101
|
|
| Other Assets |
42
|
47
|
2
|
0
|
0
|
154
|
|
| Total Assets |
77
N/A
|
94
+22%
|
19
-79%
|
1
-93%
|
8
+462%
|
1 247
+16 233%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
2
|
2
|
2
|
6
|
2
|
|
| Accrued Liabilities |
3
|
3
|
2
|
2
|
4
|
55
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
12
|
13
|
13
|
5
|
0
|
0
|
|
| Other Current Liabilities |
1
|
11
|
6
|
1
|
0
|
54
|
|
| Total Current Liabilities |
16
|
29
|
23
|
10
|
9
|
112
|
|
| Long-Term Debt |
4
|
4
|
1
|
0
|
5
|
0
|
|
| Deferred Income Tax |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
469
|
|
| Total Liabilities |
20
N/A
|
35
+76%
|
24
-30%
|
10
-57%
|
15
+41%
|
581
+3 866%
|
|
| Equity | |||||||
| Common Stock |
20
|
2
|
2
|
5
|
0
|
0
|
|
| Retained Earnings |
58
|
89
|
168
|
179
|
68
|
53
|
|
| Additional Paid In Capital |
95
|
146
|
160
|
165
|
60
|
718
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
58
N/A
|
60
+4%
|
5
N/A
|
9
-87%
|
7
+22%
|
666
N/A
|
|
| Total Liabilities & Equity |
77
N/A
|
94
+22%
|
19
-79%
|
1
-93%
|
8
+462%
|
1 247
+16 233%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
11
|
975
|
|
| Preferred Shares Outstanding |
3
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
